Advertisement
PHG vs STE
Which Stock Would AI Choose? Philips (PHG) vs. STERIS (STE) Stock Comparison
Key Takeaways
- Both PHG and STE operate in the healthcare equipment sector, with PHG focusing on broader health technology and STE specializing in infection prevention.
- PHG reported accelerated growth and margin expansion in its 2025 full-year results, shifting to profitability.
- STE delivered 9% revenue growth in Q3 fiscal 2026, with 8% organic growth on a constant currency basis.
- STE shows stronger year-to-date performance at +15.22%, compared to PHG's relatively stable trading around recent levels.
- Analyst sentiment is cautious for STE ahead of Q4 earnings, citing modest EPS growth and low ROIC (return on invested capital).
- Over the past 12 months, PHG and STE exhibited similar stock growth trajectories.
Introduction
This comparison examines PHG and STE, two prominent players in the healthcare equipment and supplies industry. Investors tracking medical devices and health technology stocks may find value in understanding their relative performance amid evolving market dynamics, including procedural demand and innovation cycles. With both companies navigating sector tailwinds like AI integration and procedural growth, this analysis highlights recent trends, financial metrics, and positioning to aid informed decision-making in portfolio allocation or trading strategies.
PHG Overview and Recent Performance
Koninklijke Philips N.V. (PHG), a global leader in health technology, provides solutions in diagnosis, treatment, monitoring, and consumer health. Its portfolio spans image-guided therapy, precision diagnosis, and connected care systems. In recent market activity, PHG has traded in a stable range around $26-$27, within a 52-week span of $21.95 to $33.44. Sentiment has been bolstered by full-year 2025 results showing accelerated comparable sales growth, strong margin expansion, and solid free cash flow, marking a shift to net profit after prior losses. Key drivers include fewer but higher-impact innovations and a positive 2026-2028 outlook, with ongoing AI advancements in healthcare visualization enhancing long-term appeal.
STE Overview and Recent Performance
STERIS plc (STE) delivers infection prevention and other procedural products and services for healthcare, pharmaceuticals, and beyond. Its offerings include sterilization technologies, surgical equipment, and healthcare IT solutions. Recently, STE shares have fluctuated around $214-$236, with a 52-week range of $209.98 to $269.44 and a market cap of approximately $21 billion. Performance reflects Q3 fiscal 2026 revenue growth of 9%, driven by 8% organic growth, alongside improved EPS. However, recent weeks show mixed momentum, with year-to-date gains of 15.22% tempered by analyst concerns over low ROIC ahead of Q4 earnings on May 12. Tariff impacts and peer comparisons have influenced cautious sentiment.
Trending AI Robots
Tickeron’s Trending AI Robots page features a curated selection of over 25 top-performing AI trading bots from its library of 351 bots, optimized for current market conditions across stocks, ETFs, and crypto. These bots employ diverse strategies like trend trading, swing trading, multi-agent signals, and take-profit/stop-loss corridors, targeting themes such as semiconductors, data centers, space, and leveraged plays. Performance stats are compelling: annualized returns range from +23.53% to +163.10%, win rates from 51.30% to 88.33%, profit factors up to 11.70, and profit-to-drawdown ratios as high as 17.02, with bots trading 3-18 tickers over timeframes from 15 minutes to 49 days. Traders can explore these for real-time signals and copy trading options suited to volatility and trends.
Head-to-Head Comparison
PHG offers a diversified health technology model emphasizing AI-driven diagnostics and therapy, contrasting STE’s niche in sterilization and infection control with service-heavy revenue. Growth drivers differ: PHG accelerates via innovation focus and MedTech tailwinds, while STE relies on steady procedural demand and acquisitions. Recent momentum favors STE with superior YTD returns, though both show comparable 12-month growth. Risk factors include PHG’s past operational challenges and STE’s tariff exposure and ROIC pressures. Sector exposure aligns in healthcare but STE benefits more from acute care cycles. Market sentiment tilts neutral, with STE’s P/E (price-to-earnings) ratio at 29.94 reflecting premium valuation versus PHG’s recovery narrative.
Tickeron AI Verdict
Tickeron’s AI currently leans toward STE based on consistent organic revenue growth, stronger recent YTD momentum, and positioning ahead of earnings catalysts. While PHG demonstrates improving stability and profitability trends, STE’s specialized exposure offers higher probability of near-term outperformance in a procedural recovery environment.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHG is a Hold and STE is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PHG’s FA Score shows that 1 FA rating(s) are green whileSTE’s FA Score has 1 green FA rating(s).
- PHG’s FA Score: 1 green, 4 red.
- STE’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PHG’s TA Score shows that 5 TA indicator(s) are bullish while STE’s TA Score has 5 bullish TA indicator(s).
- PHG’s TA Score: 5 bullish, 4 bearish.
- STE’s TA Score: 5 bullish, 3 bearish.
Price Growth
PHG (@Medical/Nursing Services) experienced а +2.12% price change this week, while STE (@Medical/Nursing Services) price change was -1.00% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.99%. For the same industry, the average monthly price growth was +2.23%, and the average quarterly price growth was -5.00%.
Reported Earning Dates
PHG is expected to report earnings on Jul 28, 2026.
STE is expected to report earnings on Aug 10, 2026.
Industries' Descriptions
@Medical/Nursing Services (+0.99% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| PHG | STE | PHG / STE | |
| Capitalization | 25.7B | 20.7B | 124% |
| EBITDA | 2.68B | 1.49B | 180% |
| Gain YTD | -0.258 | -16.619 | 2% |
| P/E Ratio | 22.95 | 26.59 | 86% |
| Revenue | 17.6B | 5.83B | 302% |
| Total Cash | 2.59B | 424M | 611% |
| Total Debt | 8.1B | 2.05B | 394% |
PHG | STE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 8 | 53 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | 18 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 93 | |
SMR RATING 1..100 | 76 | 68 | |
PRICE GROWTH RATING 1..100 | 59 | 64 | |
P/E GROWTH RATING 1..100 | 99 | 77 | |
SEASONALITY SCORE 1..100 | 26 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PHG's Valuation (5) in the Electronic Production Equipment industry is in the same range as STE (18) in the Medical Specialties industry. This means that PHG’s stock grew similarly to STE’s over the last 12 months.
STE's Profit vs Risk Rating (93) in the Medical Specialties industry is in the same range as PHG (100) in the Electronic Production Equipment industry. This means that STE’s stock grew similarly to PHG’s over the last 12 months.
STE's SMR Rating (68) in the Medical Specialties industry is in the same range as PHG (76) in the Electronic Production Equipment industry. This means that STE’s stock grew similarly to PHG’s over the last 12 months.
PHG's Price Growth Rating (59) in the Electronic Production Equipment industry is in the same range as STE (64) in the Medical Specialties industry. This means that PHG’s stock grew similarly to STE’s over the last 12 months.
STE's P/E Growth Rating (77) in the Medical Specialties industry is in the same range as PHG (99) in the Electronic Production Equipment industry. This means that STE’s stock grew similarly to PHG’s over the last 12 months.
| PHG | STE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 71% | 2 days ago 76% |
| Stochastic ODDS (%) | 2 days ago 63% | 2 days ago 60% |
| Momentum ODDS (%) | 2 days ago 64% | 2 days ago 52% |
| MACD ODDS (%) | 2 days ago 64% | 2 days ago 47% |
| TrendWeek ODDS (%) | 2 days ago 59% | 2 days ago 54% |
| TrendMonth ODDS (%) | 2 days ago 60% | 2 days ago 52% |
| Advances ODDS (%) | 7 days ago 62% | 7 days ago 50% |
| Declines ODDS (%) | 14 days ago 64% | 2 days ago 53% |
| BollingerBands ODDS (%) | 2 days ago 77% | 2 days ago 67% |
| Aroon ODDS (%) | 2 days ago 60% | 2 days ago 52% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CPSA | 27.55 | 0.02 | +0.05% |
| Calamos S&P 500 Str Alt Prt ETF-Aug | |||
| SGLC | 42.85 | -0.07 | -0.16% |
| SGI U.S. Large Cap Core ETF | |||
| UCON | 24.89 | -0.06 | -0.22% |
| First Trust Smith Unconstrained Pl BdETF | |||
| PRN | 242.35 | -3.02 | -1.23% |
| Invesco Dorsey Wright IndustrialsMomtETF | |||
| EGGY | 39.29 | -1.02 | -2.53% |
| NestYield Dynamic Income ETF | |||
PHG and
Correlation & Price change
A.I.dvisor indicates that over the last year, PHG has been loosely correlated with RYLPF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if PHG jumps, then RYLPF could also see price increases.
| Ticker / NAME | Correlation To PHG | 1D Price Change % | ||
|---|---|---|---|---|
| PHG | 100% | +1.05% | ||
| RYLPF - PHG | 56% Loosely correlated | N/A | ||
| GEHC - PHG | 53% Loosely correlated | +0.96% | ||
| ALC - PHG | 49% Loosely correlated | +2.84% | ||
| CNMD - PHG | 46% Loosely correlated | +2.10% | ||
| ENOV - PHG | 43% Loosely correlated | +4.88% | ||
More | ||||
STE and
Correlation & Price change
A.I.dvisor indicates that over the last year, STE has been loosely correlated with LH. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if STE jumps, then LH could also see price increases.